Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Emyria Ltd ( (AU:EMD) ) just unveiled an announcement.
Emyria Ltd has announced the application for the quotation of 76,443 fully paid ordinary securities on the Australian Securities Exchange (ASX). This move is part of the company’s strategic efforts to enhance its financial positioning and operational capabilities, potentially impacting its market presence and stakeholder interests.
The most recent analyst rating on (AU:EMD) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on Emyria Ltd stock, see the AU:EMD Stock Forecast page.
More about Emyria Ltd
Emyria Ltd operates in the healthcare industry, focusing on the development and commercialization of innovative medical treatments and technologies. The company is known for its work in the field of clinical trials and drug development, aiming to address unmet medical needs.
Average Trading Volume: 3,452,877
Technical Sentiment Signal: Buy
Current Market Cap: A$42.62M
See more data about EMD stock on TipRanks’ Stock Analysis page.